Published in Medical Letter on the CDC and FDA, October 2nd, 2005
As a result, Daxor has been delayed in filing the second-quarter 10Q for 2005 because of work necessitated to meet the requested changes from the SEC.
As previously announced by Daxor Corp. on August 22, 2005, Daxor filed SEC Form 12b-25 on August 12, 2005, requesting an extension of time to file...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.